Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevention of COVID-19 in patients with IBD.
Segal JP, Quraishi MN, Bhala N, Brookes MJ. Segal JP, et al. Lancet Gastroenterol Hepatol. 2020 Jul;5(7):639-640. doi: 10.1016/S2468-1253(20)30153-9. Epub 2020 May 20. Lancet Gastroenterol Hepatol. 2020. PMID: 32442546 Free PMC article. No abstract available.
Letter: faecal microbiota transplantation for IBS.
Segal JP, Mullish BH, Quraishi MN, Iqbal TH. Segal JP, et al. Aliment Pharmacol Ther. 2020 Aug;52(3):556-557. doi: 10.1111/apt.15824. Aliment Pharmacol Ther. 2020. PMID: 32656836 No abstract available.
COVID-19 vaccinations in patients with inflammatory bowel disease.
Kumar A, Quraishi MN, Segal JP, Raine T, Brookes MJ. Kumar A, et al. Among authors: segal jp. Lancet Gastroenterol Hepatol. 2020 Nov;5(11):965-966. doi: 10.1016/S2468-1253(20)30295-8. Epub 2020 Sep 21. Lancet Gastroenterol Hepatol. 2020. PMID: 32971020 Free PMC article. No abstract available.
Assessment, endoscopy, and treatment in patients with acute severe ulcerative colitis during the COVID-19 pandemic (PROTECT-ASUC): a multicentre, observational, case-control study.
Sebastian S, Walker GJ, Kennedy NA, Conley TE, Patel KV, Subramanian S, Kent AJ, Segal JP, Brookes MJ, Bhala N, Gonzalez HA, Hicks LC, Mehta SJ, Lamb CA; PROTECT-ASUC Study Group. Sebastian S, et al. Among authors: segal jp. Lancet Gastroenterol Hepatol. 2021 Apr;6(4):271-281. doi: 10.1016/S2468-1253(21)00016-9. Epub 2021 Feb 2. Lancet Gastroenterol Hepatol. 2021. PMID: 33545083 Free PMC article.
The impact of SARS-CoV-2 variants on IBD management.
Segal JP, Kumar A, Raine T, Lamb CA, Brookes MJ. Segal JP, et al. Lancet Gastroenterol Hepatol. 2021 May;6(5):343-344. doi: 10.1016/S2468-1253(21)00075-3. Epub 2021 Mar 10. Lancet Gastroenterol Hepatol. 2021. PMID: 33711289 Free PMC article. No abstract available.
Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab.
Kennedy NA, Goodhand JR, Bewshea C, Nice R, Chee D, Lin S, Chanchlani N, Butterworth J, Cooney R, Croft NM, Hart AL, Irving PM, Kok KB, Lamb CA, Limdi JK, Macdonald J, McGovern DP, Mehta SJ, Murray CD, Patel KV, Pollok RC, Raine T, Russell RK, Selinger CP, Smith PJ, Bowden J, McDonald TJ, Lees CW, Sebastian S, Powell N, Ahmad T; Contributors to the CLARITY IBD study. Kennedy NA, et al. Gut. 2021 May;70(5):865-875. doi: 10.1136/gutjnl-2021-324388. Epub 2021 Mar 22. Gut. 2021. PMID: 33753421
223 results